Please provide your email address to receive an email when new articles are posted on . The FDA has approved an expanded indication of Boston Scientific’s spinal cord stimulation system that treats ...
Marlborough medical device manufacturer Boston Scientific Corp. has announced a limited market release of a new pain-relief system that uses electrical impulses in the spine to block pain signals. The ...
Please provide your email address to receive an email when new articles are posted on . The WaveWriter is approved to treat low back and leg pain in patients without prior back surgery. The system ...
MARLBOROUGH, Mass., Sept. 30, 2020 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the European launch of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) Systems. The ...
Boston Scientific is releasing in the United States its Wavewriter Alpha line of spinal cord stimulators. The four Wavewriter Alpha pain management devices provide Bluetooth connectivity, allow ...
System offers multiple non-drug therapies for people with chronic pain PARIS, Jan. 31, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Spectra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback